Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RUBY

Rubius Therapeutics (RUBY) Stock Price, News & Analysis

Rubius Therapeutics logo

About Rubius Therapeutics Stock (NASDAQ:RUBY)

Advanced Chart

Key Stats

Today's Range
$0.06
$0.06
50-Day Range
$0.02
$0.06
52-Week Range
$0.00
$0.38
Volume
755,858 shs
Average Volume
1.15 million shs
Market Capitalization
$5.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RUBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rubius Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RUBY Stock News Headlines

How to Get the Exclusive Rubius Fortnite Drop
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Rubius Therapeutics Inc RUBY
RUBY - Rubius Therapeutics, Inc.
North American Morning Briefing: Alphabet, -2-
See More Headlines

RUBY Stock Analysis - Frequently Asked Questions

Rubius Therapeutics, Inc. (NASDAQ:RUBY) posted its quarterly earnings results on Monday, November, 8th. The company reported ($0.55) earnings per share for the quarter, beating analysts' consensus estimates of ($0.56) by $0.01.

Rubius Therapeutics (RUBY) raised $200 million in an IPO on Wednesday, July 18th 2018. The company issued 9,500,000 shares at a price of $20.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rubius Therapeutics investors own include Meta Platforms (META), Sorrento Therapeutics (SRNE), Pfizer (PFE), Bristol Myers Squibb (BMY), OPKO Health (OPK), Tesla (TSLA) and Athenex (ATNX).

Company Calendar

Last Earnings
11/08/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:RUBY
CIK
1709401
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
90,480,000
Free Float
85,687,000
Market Cap
$5.16 million
Optionable
Not Optionable
Beta
2.59
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:RUBY) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners